Showing results (181-190 of 1,150) with videos related to
Sort By:
Pageof 115
The Journal of Clinical Psychiatry|July 9, 2014
The efficacy of adjunctive N-acetylcysteine in major depressive disorder: a double-blind, randomized, placebo-controlled trialMichael Berk, Olivia M Dean, Sue M Cotton, et al.Acta Neuropsychiatrica|July 17, 2018
Mediator effects of parameters of inflammation and neurogenesis from a N-acetyl cysteine clinical-trial for bipolar depressionBruna Panizzutti, Chiara Bortolasci, Kyoko Hasebe, et al.BMC Medicine|August 16, 2012
Maintenance N-acetyl cysteine treatment for bipolar disorder: a double-blind randomized placebo controlled trialMichael Berk, Olivia M Dean, Sue M Cotton, et al.Iranian Journal of Child Neurology|March 14, 2015
Beta-lactam antibiotics as a possible novel therapy for managing epilepsy and autism, a case report and review of literatureAhmad Ghanizadeh, Michael BerkMedical Gas Research|June 8, 2013
Molecular hydrogen: an overview of its neurobiological effects and therapeutic potential for bipolar disorder and schizophreniaAhmad Ghanizadeh, Michael BerkThe International Journal of Social Psychiatry|July 26, 2015
Nonsuicidal self-injury in Indian adolescents: Nonexistent or unacknowledged?Shilpa Aggarwal, Michael BerkNeuroscience Letters|December 3, 2014
Association of paraoxonase (PON)1 activity, glutathione S-transferase GST T1/M1 and STin.2 polymorphisms with comorbidity of tobacco use disorder and mood disordersSandra Odebrecht Vargas Nunes, Márcia Regina Pizzo de Castro, Estefania Gastaldello Moreira, et al.Current Alzheimer Research|February 20, 2016
The Putative Use of Lithium in Alzheimer's DiseaseGerwyn Morris, Michael BerkSchizophrenia Bulletin|April 9, 2014
Th17 pathway-mediated immunopathogenesis of schizophrenia: mechanisms and implicationsMonojit Debnath, Michael BerkMolecular Neurobiology|December 1, 2016
Functional Implications of the IL-23/IL-17 Immune Axis in SchizophreniaMonojit Debnath, Michael BerkPageof 115